Introduction: We aimed to evaluate the effects of hyperbaric oxygen therapy (HBOT) on erectile function in patients who had no cavernosal or urethral injury by using International Index of Erectile Function (IIEF) questionnaire. Materials and Methods: The male patients who were treated by HBOT for several diseases between July 2017 and September 2017 were examined. All patients filled the IIEF questionnaire form before the first day and after the last day of HBOT and a questionnaire including demographic characteristics and medical history. The effects of demographic characteristics and risk factors on erectile function were evaluated, and the IIEF domain scores of patients in first day and last day of HBOT were compared. Results: Totally, 50 patients were included in the study between July 2017 and September 2017 and the mean age was 59.38 ± 13.77. The mean post-HBOT IIEF-EF score of patients was significantly higher than the mean pre-HBOT IIEF-EF score of patients (15.74 ± 10.52 vs. 19.50 ± 10.91; p < 0.001). The mean post-HBOT IIEF scores of other domains including intercourse satisfaction, orgasmic function, sexual desire, and overall satisfaction were also significantly higher than pre-HBOT scores. Conclusions: HBOT may be a good alternative treatment or adjunctive treatment for erectile dysfunction.

Hatzimouratidis K, Giuliano F, Moncada I, Muneer A, Salonia A, Verze P: Guideline Associates: Parnham A, Serefoglu EC: EAU Guidelines on Erectile Dysfunction, Premature Ejaculation, Penile Curvature and Priapism. Edn. presented at the EAU Annual Congress London. Arnhem, EAU Guidelines Office, 2017.
Fisher WA, Eardley I, McCabe M, Sand M: Erectile dysfunction (ED) is a shared sexual concern of couples I: couple conceptions of ED. J Sex Med 2009; 6: 2746–2760.
Zhang X, Yang B, Li N, Li H: Prevalence and risk factors for erectile dysfunction in Chinese adult males. J Sex Med 2017; 14: 1201–1208.
Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U: Epidemiology of erectile dysfunction: results of the “cologne male survey”. Int J Impot Res 2000; 12: 305–311.
Quilter M, Hodges L, von Hurst P, Borman B, Coad J: Male sexual function in New Zealand: a population-based cross-sectional survey of the prevalence of erectile dysfunction in men aged 40–70 years. J Sex Med 2017; 14: 928–936.
Nguyen HMT, Gabrielson AT, Hellstrom WJG: Erectile dysfunction in young men-A review of the prevalence and risk factors. Sex Med Rev 2017; 5: 508–520.
Kalyvianakis D, Hatzichristou D: Low-intensity shockwave therapy improves hemodynamic parameters in patients with vasculogenic erectile dysfunction: a triplex ultrasonography-based sham-controlled trial. J Sex Med 2017; 14: 891–897.
Müller A, Tal R, Donohue JF, Akin-Olugbade Y, Kobylarz K, Paduch D, Cutter SC, Mehrara BJ, Scardino PT, Mulhall JP: The effect of hyperbaric oxygen therapy on erectile function recovery in a rat cavernous nerve injury model. J Sex Med 2008; 5: 562–570.
Cormier J, Theriot M: Patient diagnosed with chronic erectile dysfunction refractory to PDE 5 inhibitor therapy reports improvement in function after hyperbaric oxygen therapy. Undersea Hyperb Med 2016; 43: 463–465.
Tang H, Sun Y, Xu C, Zhou T, Gao X, Wang L: Effects of hyperbaric oxygen therapy on tumor growth in murine model of PC-3 prostate cancer cell line. Urology 2009; 73: 205–208.
Yuan JB, Yang LY, Wang YH, Ding T, Chen TD, Lu Q: Hyperbaric oxygen therapy for recovery of erectile function after posterior urethral reconstruction. Int Urol Nephrol 2011; 43: 755–761.
Ribeiro de Oliveira TM, Carmelo Romão AJ, Gamito Guerreiro FM, Matos Lopes TM. Hyperbaric oxygen therapy for refractory radiation-induced hemorrhagic cystitis. Int J Urol 2015; 22: 962–966.
Mindrup SR, Kealey GP, Fallon B: Hyperbaric oxygen for the treatment of fournier's gangrene. J Urol 2005; 173: 1975–1977.
Tanaka T, Nitta Y, Morimoto K, Nishikawa N, Nishihara C, Tamada S, Kawashima H, Nakatani T: Hyperbaric oxygen therapy for painful bladder syndrome/interstitial cystitis resistant to conventional treatments: long-term results of a case series in Japan. BMC Urol 2011; 11: 11.
Boratav K: İstanbul ve Anadolu’dan Sınıf Profilleri. Tarih Vakfı Yurt Yayınları, İstanbul, 1995.
Cohen J: Statistical Power Analysis for the Behavioural Sciences. New York, Erlbaum, 1988.
Cimsit M: The history of hyperbaric treatment; in Cimsit M (ed): Hyperbaric Medicine (ed 1). Ankara, Eflatun Publishing House, Place published, 2009, pp 1–12.
Churchill-Davidson I, Sanger C, Thomlinson RH: High-pressure oxygen and radiotherapy. Lancet 1955; 268: 1091–1095.
Degener S, Pohle A, Strelow H, Mathers MJ, Zumbé J, Roth S, Brandt AS: Long-term experience of hyperbaric oxygen therapy for refractory radio- or chemotherapy-induced haemorrhagic cystitis. BMC Urol 2015; 15: 38.
Nakada T, Nakada H, Yoshida Y, Nakashima Y, Banya Y, Fujihira T, Karasawa K: Hyperbaric oxygen therapy for radiation cystitis in patients with prostate cancer: a long-term follow-up study. Urol Int 2012; 89: 208–214.
Rosa I, Guerreiro F: Hyperbaric oxygen therapy for the treatment of Fournier’s Gangrene: a review of 34 cases. Acta Med Port 2015; 28: 619–623.
Mehl AA, Nogueira Filho DC, Mantovani LM, Grippa MM, Berger R, Krauss D, et al: Management of Fournier’s gangrene: experience of a university hospital of Curitiba. Rev Col Bras Cir 2010; 37: 435–441.
Li C, Zhou X, Liu LF, Qi F, Chen JB, Zu XB: Hyperbaric oxygen therapy as an adjuvant therapy for comprehensive treatment of Fournier’s Gangrene. Urol Int 2015; 94: 453–458.
Shupak A, Shoshani O, Goldenberg I, Barzilai A, Moskuna R, Bursztein S: Necrotizing fasciitis: an indication for hyperbaric oxygenation therapy? Surgery 1997; 118: 873–878.
Chiles KA, Staff I, Johnson-Arbor K, Champagne A, McLaughlin T, Graydon RJ: A -double-blind, randomized trial on the efficacy and safety of hyperbaric oxygenation -therapy in the preservation of erectile function after radical protastectomy. J Urol 2017:pii:S0022–5347(17)77720–8.
Hart GB, Strauss MB: Effects of cigarette smoking on tissue gas exchange during hyperbaric exposures. Undersea Hyperb Med 2010; 37: 73–87.
Yen CY, Tu YK, Ma CH, Yeh JH, Kao FC, Yu SW, Lee MS, Chou YC, Ueng SW: Measurement of tibial endothelial cell function after cigarette smoking, cessation of smoking and hyperbaric oxygen therapy. Injury 2008; 39(suppl 4): 40–46.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.